Idera Pharmaceuticals reported $0 in Sales Revenues for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbott ABT:US $ 11257M 638M
Agenus AGEN:US $ 20.93M 5.01M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Amgen AMGN:US $ 6594M 356M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Cytrx CYTR:US 0 0
Dynavax Technologies DVAX:US $ 256.46M 142.47M
Eli Lilly And LLY:US $ 6488M 1322M
Gilead Sciences GILD:US $ 6260M 330M
GlaxoSmithKline GSK:LN 692900M 26100M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Nektar Therapeutics NKTR:US $ 21.58M 3.24M
Pfizer PFE:US $ 27742M 2081M
Roche Holding ROG:VX 16.44B 474M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M